[WPRTS] QoQ Cumulative Quarter Result on 30-Sep-2014 [#3]

Stock
[WPRTS] WESTPORTS HOLDINGS BERHAD
Announcement Date
06-Nov-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Sep-2014 [#3]
Profit Trend
QoQ- 60.85%
YoY- 22.45%
Quarter Report
Latest QR
Upcoming QR
WPRTS's Result
WPRTS's Financial Summary
View:
Show?
Cumulative Result
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Revenue 804,002 398,722 1,562,079 1,177,592 772,184 363,158 1,712,618 -39.67%
PBT 321,647 159,600 578,781 436,613 280,338 131,635 517,008 -27.18%
Tax -79,369 -39,414 -66,576 -64,209 -48,809 -22,599 -81,703 -1.91%
NP 242,278 120,186 512,205 372,404 231,529 109,036 435,305 -32.41%
-
NP to SH 242,278 120,186 512,205 372,404 231,529 109,036 435,305 -32.41%
-
Tax Rate 24.68% 24.70% 11.50% 14.71% 17.41% 17.17% 15.80% -
Total Cost 561,724 278,536 1,049,874 805,188 540,655 254,122 1,277,313 -42.25%
-
Net Worth 1,803,549 1,674,651 1,764,334 1,624,523 1,657,600 1,534,841 1,604,064 8.15%
Dividend
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Div 181,412 - 383,625 173,909 173,909 - 1,380,027 -74.24%
Div Payout % 74.88% - 74.90% 46.70% 75.11% - 317.03% -
Equity
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Net Worth 1,803,549 1,674,651 1,764,334 1,624,523 1,657,600 1,534,841 1,604,064 8.15%
NOSH 3,410,000 3,410,000 3,410,000 3,410,000 3,410,000 3,410,000 3,410,000 0.00%
Ratio Analysis
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
NP Margin 30.13% 30.14% 32.79% 31.62% 29.98% 30.02% 25.42% -
ROE 13.43% 7.18% 29.03% 22.92% 13.97% 7.10% 27.14% -
Per Share
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
RPS 23.58 11.69 45.81 34.53 22.64 10.65 50.22 -39.67%
EPS 7.10 3.52 15.02 10.92 6.79 3.20 13.86 -36.05%
DPS 5.32 0.00 11.25 5.10 5.10 0.00 40.47 -74.24%
NAPS 0.5289 0.4911 0.5174 0.4764 0.4861 0.4501 0.4704 8.15%
Adjusted Per Share Value based on latest NOSH - 3,410,000
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
RPS 23.58 11.69 45.81 34.53 22.64 10.65 50.22 -39.67%
EPS 7.10 3.52 15.02 10.92 6.79 3.20 13.86 -36.05%
DPS 5.32 0.00 11.25 5.10 5.10 0.00 40.47 -74.24%
NAPS 0.5289 0.4911 0.5174 0.4764 0.4861 0.4501 0.4704 8.15%
Price Multiplier on Financial Quarter End Date
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Date 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 -
Price 4.23 4.02 3.36 3.05 2.69 2.53 2.53 -
P/RPS 17.94 34.38 7.33 8.83 11.88 23.76 5.04 133.67%
P/EPS 59.54 114.06 22.37 27.93 39.62 79.12 19.82 108.61%
EY 1.68 0.88 4.47 3.58 2.52 1.26 5.05 -52.08%
DY 1.26 0.00 3.35 1.67 1.90 0.00 16.00 -81.71%
P/NAPS 8.00 8.19 6.49 6.40 5.53 5.62 5.38 30.37%
Price Multiplier on Announcement Date
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Date 31/07/15 30/04/15 11/02/15 06/11/14 23/07/14 02/05/14 13/02/14 -
Price 4.01 4.50 3.50 2.90 2.80 2.54 2.51 -
P/RPS 17.01 38.49 7.64 8.40 12.36 23.85 5.00 126.70%
P/EPS 56.44 127.68 23.30 26.55 41.24 79.44 19.66 102.38%
EY 1.77 0.78 4.29 3.77 2.42 1.26 5.09 -50.64%
DY 1.33 0.00 3.21 1.76 1.82 0.00 16.12 -81.13%
P/NAPS 7.58 9.16 6.76 6.09 5.76 5.64 5.34 26.38%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment